S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6994 +0.01%
PRE-MKT · 05:45 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead
MK
INSIDER · ROIV · Roivant Sciences Ltd. · DIRECTOR

MANCHESTER KEITH S

Every open-market transaction filed under this name, Nov 16 to Nov 17.

Filings
7
0 buys · 7 sells
Bought
—
open market, at cost
Sold
$53.5M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 17ROIVRoivant Sciences Ltd.DirectorSell798$38.24$31K+1.3%
Nov 17ROIVRoivant Sciences Ltd.DirectorSell525,507$38.24$20.1M+1.3%
Nov 17ROIVRoivant Sciences Ltd.DirectorSell75,716$38.24$2.9M+1.3%
Nov 16ROIVRoivant Sciences Ltd.DirectorSell131,073$38.99$5.1M−0.7%
Nov 16ROIVRoivant Sciences Ltd.DirectorSell18,927$38.99$738K−0.7%
Nov 16ROIVRoivant Sciences Ltd.DirectorSell550,280$39.17$21.6M−1.1%
Nov 16ROIVRoivant Sciences Ltd.DirectorSell79,461$39.17$3.1M−1.1%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.